Why the study?
When should laboratory testing of DOAC plasma activity levels be considered in patients on DOAC therapy?
When should laboratory testing of DOAC plasma activity levels be considered in patients on DOAC therapy?
While DOACs do not require routine monitoring, 24/7 availability of target-specific laboratory testing is recommended to guide management in acute clinical scenarios like bleeding or thrombosis.
Supports targeted DOAC testing in acute events; leaves open need for prospective validation before broader adoption.
INTRODUCTION: Direct oral anticoagulants (DOACs) are increasingly prescribed for prevention of thromboembolic stroke, as well as for prevention and treatment of venous thromboembolism. Dose adjustment based on laboratory testing is not required; however, there are several potential situations that deserve insight into a DOAC plasma activity level. METHODS: Based on a series of real-life case descriptions, we discuss indications for dedicated DOAC testing, as well as the interpretation and consequences. RESULTS: Testing of DOACs in selected patients may help to better interpret acute situations such as bleeding or thrombosis while on anticoagulation, but also suspected drug failure, drug accumulation, or lack of adherence. CONCLUSION: The 24/7 availability of target-specific tests with adequate calibration is recommended to support the clinician in the interpretation and where needed adjustment of the management of patients on DOACs. The relevance of laboratory-guided DOAC management, particularly in the elderly, merits further study.
No takes yet. Share an insight, caveat, or question.
Cate et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: